Case Reports
[Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo]
[Article in
Italian]
Affiliations
- PMID: 18581968
Item in Clipboard
Case Reports
[Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo]
[Article in
Italian]
Recenti Prog Med.
2008 May.
Abstract
Pure red cell aplasia (PRCA) is a rare condition described in patients with chronic kidney disease during alpha-Epo treatment subcutaneous administered generated by anti-R-Epo antibodies. Recently two cases of PRCA have been reported in patients affected by myelodysplastic syndrome treated with R-Epo. We described one more case of PRCA in a patient with refractory anemia treated with R-Epo.
Similar articles
-
[Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].Rinsho Ketsueki. 2007 May;48(5):391-6. Rinsho Ketsueki. 2007. PMID: 17571584 Japanese.
-
High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases.Nephrol Dial Transplant. 2004 Aug;19(8):2121-5. doi: 10.1093/ndt/gfh307. Nephrol Dial Transplant. 2004. PMID: 15252171
-
Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland.Przegl Lek. 2006;63(9):810-4. Przegl Lek. 2006. PMID: 17479877
-
[Pure red cell aplasia as a complication of treatment with recombinant human erythropoietin].Pol Merkur Lekarski. 2004 Oct;17(100):407-9. Pol Merkur Lekarski. 2004. PMID: 15690716 Review. Polish.
-
Pure red cell aplasia secondary to treatment with erythropoietin.J Nephrol. 2003 Jul-Aug;16(4):461-6. J Nephrol. 2003. PMID: 14696747 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials